Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Microplate Designed for FCS

By Drug Discovery Trends Editor | April 25, 2013

Greiner Bio-One, a leading technology partner for the diagnostic and pharmaceutical industries, is unveiling the 96 well SensoPlate Plus. As a microscopy plate with a transparent borosilicate glass bottom and a black cycloolefin frame, SensoPlate Plus was developed especially for use in high-resolution microscopy and fluorescence correlation spectroscopy (FCS).

Microscopic applications such as confocal microscopy and fluorescence correlation spectroscopy are sophisticated methods that can benefit from SensoPlate Plus. Consisting of a black cycloolefin frame, 96 well SensoPlate Plus features an ultra-clear borosilicate 175 ?m cover glass bottom affixed with a low autofluorescence adhesive. Resistant to dimethyl sulfoxide and 70-percent ethanol, SensoPlate Plus is suitable for cell culture use.

The SensoPlate Plus glass bottom microplate offers an optimised geometry to facilitate trouble-free measurements and high resolution imaging. Perimeter well microscopy is significantly enhanced due to a condensed distance between the microplate well and skirt bottom. Circular wells prevent disruptive shadow with the smallest possible meniscus lens, and a slightly enlarged well diameter allows an increased working volume. A perimeter ditch may be filled with liquid to minimise edge effect during lengthy incubations.

96 well SensoPlate Plus glass bottom microplates are featured sterile with cell culture treatment, lid, individually wrapped, 16 per case.

Greiner Bio-One

 


Filed Under: Drug Discovery

 

Related Articles Read More >

Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE